Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3189
+0.0120 (3.91%)
At close: Aug 22, 2025, 4:00 PM
0.3123
-0.0066 (-2.07%)
After-hours: Aug 22, 2025, 7:55 PM EDT
Co-Diagnostics Stock Forecast
CODX's stock price has decreased by -79.69% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Co-Diagnostics stock have a consensus rating of "Buy" and an average price target of $5.50, which forecasts a 1,624.68% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $10.
Price Target: $5.50 (+1,624.68%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Co-Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +3,035.78% | Aug 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +3,035.78% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +213.58% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +370.37% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | +370.37% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
484.50K
from 3.92M
Decreased by -87.63%
Revenue Next Year
688.50K
from 484.50K
Increased by 42.11%
EPS This Year
-1.09
from -1.24
EPS Next Year
-0.43
from -1.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 997,500 | 1.4M | 41.0M | ||
| Avg | 484,500 | 688,500 | 39.8M | ||
| Low | n/a | n/a | 38.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -74.5% | 192.7% | 5,847.7% | ||
| Avg | -87.6% | 42.1% | 5,677.8% | ||
| Low | - | - | 5,451.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.71 | -0.36 | -0.34 | ||
| Avg | -1.09 | -0.43 | -0.33 | ||
| Low | -1.43 | -0.49 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.